Description
An αν integrin receptor antagonist (IC50s = 1.2-3.7 nM); inhibits hallmarks of bone marrow invasion in metastatic prostate cancer in vitro and in vivo; reduces EMT and migration of PC-3M-Pro4/luc cells in a dose-dependent manner without inhibiting cell growth; induces detachment and necrosis of GL-261 and SMA-560 murine glioma cells,
Formal name: 3-[[2,5-dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(4-methoxyphenyl)sulfonyl]-L-alanine
Synonyms:
Molecular weight: 595.7
CAS: 1320346-97-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Death|Necrosis||Research Area|Cancer|Cell Migration & Metastasis